SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: John McCarthy who wrote (14123)11/15/2004 11:43:45 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 52153
 
Adam Baby:

>> events that high-risk-loving biotech investors crave <<

You are certainly aware, that's a subset of biotech investors. My biotech investing is low-risk, and it has been for many proven years. You know that there's a better way to represent biotech investors, no lumping.

Big-science small caps and a balanced basket? You know damn well that it's been a SAFE route -- for years -- to superior return.

But I do own a little PARS, and you're certainly correct.

Cheers!

Rick



To: John McCarthy who wrote (14123)11/15/2004 1:03:38 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Thanks for posting that.

Nice to see them quoting Harry. Even nicer if the trial works, of course. <g>

pricing in the range of $5,000 per course of therapy

Seems like they could charge more if it's truly effective. If it gets you out of the ICU a few days earlier, or means a better recovery, then $5k is cheap. TBI is incredibly expensive - I've not seen cost figures, but I'm guessing that for moderate injuries $100k has to be very much the bottom of the range.

Stock has bounced back recently - up nearly 50% off its lows of about a month ago. No idea what that means, but my cynical side says a small Israeli company is likely to be leakier than a US company.

(No position)

Peter



To: John McCarthy who wrote (14123)11/15/2004 4:48:21 PM
From: zeta1961  Read Replies (1) | Respond to of 52153
 
that patients given dexanabinol exhibit a statistically significant reduction in TBI compared with placebo patients.

WHOA..A 100 bagger!!!!..a drug that's going to make a TBI go away!!<g>.."My head was walloped in a head on collision, they gave me some drug that's like pot and I just feel like, you know, ..no bigggie..just a concussion..

Adam..please have Dr. Tracy read your pieces for scientific accuracy before you submit them..

Seriously, depending on what the 6 month Glasgow outcome data show..10K will be a bargain..when one also calculates the rehabilition costs of these patients..No position..I truly hope it helps..

Zeta@TookCareofTooManyYounginsWhoseLifeWasDecimatedbecauseOfTBI